...
首页> 外文期刊>World Journal of Gastroenterology >Fibrin sealant for closure of mucosal penetration at the cardia during peroral endoscopic myotomy: A retrospective study at a single center
【24h】

Fibrin sealant for closure of mucosal penetration at the cardia during peroral endoscopic myotomy: A retrospective study at a single center

机译:纤维蛋白密封剂用于封闭经口内镜下肌切开术期间the门粘膜穿透的封闭性:单个中心的回顾性研究

获取原文

摘要

AIM To assess the efficacy and safety of fibrin sealant for closure of mucosal penetration at the cardia during peroral endoscopic myotomy (POEM). METHODS Twenty-four patients who underwent POEM and experienced mucosal injury of the cardia during the procedure were retrospectively identified. Of the 24 patients, 21 had mucosal penetration and 3 had only slight mucosal damage without penetration. The 21 patients with mucosal penetration received fibrin sealant for closure at the site of penetration. Penetration-related characteristics, treatment, and recovery were reviewed for all 21 patients to assess the efficacy and safety of fibrin sealant for closure of mucosal penetration at the cardia. Clinical data, including general characteristics, procedure-related parameters, Eckardt scores, lower esophageal sphincter pressures (LESP), and esophagogastroduodenoscopy (EGD) results, were analyzed to determine their influence on treatment success after mucosal penetration during POEM. RESULTS All 21 patients had a solitary mucosal penetration in the cardia (12 in esophageal region of the cardia, 9 in the stomach region of the cardia, and 1 in both the esophageal and stomach regions). Twelve had a hole-like penetration and 9 had a linear penetration. For those with a hole-like penetration, the mean size was 0.14 cm2 (0.02-0.32 cm2). For those with a linear penetration, the median size was 0.37 cm (0.10-1.00 cm). Closure of the mucosal penetration using fibrin sealant was performed successfully in all 21 patients (two patients required 5 mL fibrin sealant, and the remaining 19 patients required 2.5 mL). Two patients had a nasogastric tube placed for five days after POEM; the remaining 19 patients were kept fasting for 3 d. All 21 patients were discharged after a median of 5 d (range: 5-7 d) postoperatively. During a median 42 mo (range: 9-62 mo) follow-up, all 21 patients with a mucosal penetration successfully healed without the occurrence of infection, ulcer, or esophagitis. Furthermore, the median LESP decreased from 31.9 mmHg (range: 21.9-67.1 mmHg) preoperatively to 20.3 mmHg (range: 6.0-41.0 mmHg) postoperatively ( P < 0.05). The median preoperative and postoperative Eckardt scores were 5.0 (range; 4-10) and 1.0 (range: 0-4), respectively ( P < 0.05). Of the 21 patients with mucosal penetration, symptom remission, which is defined as a postoperative Eckardt score ≤ 3, was achieved in 20 patients (95.2%) indicating that mucosal penetration did not influence the success of POEM treatment if closed successfully using fibrin sealant. CONCLUSION Fibrin sealant is safe and effective for closure of mucosal penetration during POEM. Mucosal penetrations do not appear to influence the treatment success of POEM if closed successfully using fibrin sealant. Additional studies regarding the feasibility, efficacy, and safety of fibrin sealant for closure of larger mucosal penetrations is warranted.
机译:目的评估纤维蛋白封闭剂在经口内镜下肌切开术(POEM)期间封闭the门粘膜渗透的功效和安全性。方法回顾性分析24例行POEM手术并经历experienced门粘膜损伤的患者。在24例患者中,有21例有粘膜穿透性,而3例仅有轻微的粘膜损伤而无穿透。 21例粘膜穿透性患者在穿透部位接受了纤维蛋白封闭剂封闭。回顾了所有21例患者的渗透相关特征,治疗和恢复情况,以评估血纤蛋白封闭剂封闭closure门粘膜渗透的功效和安全性。分析了临床数据,包括一般特征,与手术相关的参数,Eckardt评分,较低的食管括约肌压力(LESP)和食管胃十二指肠镜检查(EGD)结果,以确定它们对POEM粘膜穿透后治疗成功的影响。结果所有21例患者的the门均发生了单独的粘膜穿透((门的食管区域为12例,the门的胃区域为9例,食管和胃区域均为1例)。十二个具有类似孔的穿透,而九个具有线性穿透。对于那些具有孔状穿透的患者,平均大小为0.14 cm 2 (0.02-0.32 cm 2 )。对于具有线性穿透力的对象,中位大小为0.37厘米(0.10-1.00厘米)。在所有21例患者中,使用纤维蛋白封闭剂成功地完成了粘膜渗透的封闭(两名患者需要5 mL纤维蛋白封闭剂,其余19例患者需要2.5 mL)。 POEM术后5天,有2例患者置入了鼻胃管。其余19例患者禁食3 d。术后中位5 d(范围:5-7 d)后全部21例患者出院。在中位的42个月(范围:9-62个月)随访期间,所有21例具有粘膜穿透的患者均成功治愈,而未发生感染,溃疡或食管炎。此外,LESP的中值从术前的31.9 mmHg(范围:21.9-67.1 mmHg)降至术后的20.3 mmHg(范围:6.0-41.0 mmHg)(P <0.05)。术前和术后Eckardt评分的中位数分别为5.0(范围:4-10)和1.0(范围:0-4)(P <0.05)。在这21例黏膜穿透患者中,有20例患者达到了症状缓解(定义为术后Eckardt评分≤3)(95.2%),这表明如果使用纤维蛋白密封剂成功封闭,黏膜穿透不会影响POEM治疗的成功。结论血纤蛋白封闭剂在POEM过程中安全有效地封闭粘膜渗透。如果使用纤维蛋白封闭剂成功封闭,则粘膜穿透似乎不会影响POEM的治疗成功。关于纤维蛋白封闭剂封闭较大的粘膜穿透的可行性,功效和安全性的其他研究值得进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号